200 related articles for article (PubMed ID: 11884437)
1. BCR engagement induces Fas resistance in primary B cells in the absence of functional Bruton's tyrosine kinase.
Tumang JR; Negm RS; Solt LA; Schneider TJ; Colarusso TP; Hastings WD; Woodland RT; Rothstein TL
J Immunol; 2002 Mar; 168(6):2712-9. PubMed ID: 11884437
[TBL] [Abstract][Full Text] [Related]
2. NF-kappa B is required for surface Ig-induced Fas resistance in B cells.
Schram BR; Rothstein TL
J Immunol; 2003 Mar; 170(6):3118-24. PubMed ID: 12626568
[TBL] [Abstract][Full Text] [Related]
3. An essential role for Bruton's [corrected] tyrosine kinase in the regulation of B-cell apoptosis.
Anderson JS; Teutsch M; Dong Z; Wortis HH
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10966-71. PubMed ID: 8855292
[TBL] [Abstract][Full Text] [Related]
4. Reduced dosage of Bruton's tyrosine kinase uncouples B cell hyperresponsiveness from autoimmunity in lyn-/- mice.
Whyburn LR; Halcomb KE; Contreras CM; Lowell CA; Witte ON; Satterthwaite AB
J Immunol; 2003 Aug; 171(4):1850-8. PubMed ID: 12902486
[TBL] [Abstract][Full Text] [Related]
5. Cutting edge: CD40 engagement eliminates the need for Bruton's tyrosine kinase in B cell receptor signaling for NF-kappa B.
Mizuno T; Rothstein TL
J Immunol; 2003 Mar; 170(6):2806-10. PubMed ID: 12626529
[TBL] [Abstract][Full Text] [Related]
6. Cellular maturation defects in Bruton's tyrosine kinase-deficient immature B cells are amplified by premature B cell receptor expression and reduced by receptor editing.
Middendorp S; Hendriks RW
J Immunol; 2004 Feb; 172(3):1371-9. PubMed ID: 14734712
[TBL] [Abstract][Full Text] [Related]
7. Impaired B cell maturation in mice lacking Bruton's tyrosine kinase (Btk) and CD40.
Khan WN; Nilsson A; Mizoguchi E; Castigli E; Forsell J; Bhan AK; Geha R; Sideras P; Alt FW
Int Immunol; 1997 Mar; 9(3):395-405. PubMed ID: 9088978
[TBL] [Abstract][Full Text] [Related]
8. Impaired precursor B cell differentiation in Bruton's tyrosine kinase-deficient mice.
Middendorp S; Dingjan GM; Hendriks RW
J Immunol; 2002 Mar; 168(6):2695-703. PubMed ID: 11884435
[TBL] [Abstract][Full Text] [Related]
9. Regulation of B lymphocyte development and activation by Bruton's tyrosine kinase.
Khan WN
Immunol Res; 2001; 23(2-3):147-56. PubMed ID: 11444380
[TBL] [Abstract][Full Text] [Related]
10. Complementary roles for CD19 and Bruton's tyrosine kinase in B lymphocyte signal transduction.
Fujimoto M; Poe JC; Satterthwaite AB; Wahl MI; Witte ON; Tedder TF
J Immunol; 2002 Jun; 168(11):5465-76. PubMed ID: 12023340
[TBL] [Abstract][Full Text] [Related]
11. Bruton's tyrosine kinase targets NF-kappaB to the bcl-x promoter via a mechanism involving phospholipase C-gamma2 following B cell antigen receptor engagement.
Petro JB; Castro I; Lowe J; Khan WN
FEBS Lett; 2002 Dec; 532(1-2):57-60. PubMed ID: 12459462
[TBL] [Abstract][Full Text] [Related]
12. Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement.
Petro JB; Rahman SM; Ballard DW; Khan WN
J Exp Med; 2000 May; 191(10):1745-54. PubMed ID: 10811867
[TBL] [Abstract][Full Text] [Related]
13. Independent and opposing roles for Btk and lyn in B and myeloid signaling pathways.
Satterthwaite AB; Lowell CA; Khan WN; Sideras P; Alt FW; Witte ON
J Exp Med; 1998 Sep; 188(5):833-44. PubMed ID: 9730885
[TBL] [Abstract][Full Text] [Related]
14. Bruton's tyrosine kinase as an inhibitor of the Fas/CD95 death-inducing signaling complex.
Vassilev A; Ozer Z; Navara C; Mahajan S; Uckun FM
J Biol Chem; 1999 Jan; 274(3):1646-56. PubMed ID: 9880544
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.
Buhl AM; Cambier JC
J Immunol; 1999 Apr; 162(8):4438-46. PubMed ID: 10201980
[TBL] [Abstract][Full Text] [Related]
16. A balance of Bruton's tyrosine kinase and SHIP activation regulates B cell receptor cluster formation by controlling actin remodeling.
Liu C; Miller H; Hui KL; Grooman B; Bolland S; Upadhyaya A; Song W
J Immunol; 2011 Jul; 187(1):230-9. PubMed ID: 21622861
[TBL] [Abstract][Full Text] [Related]
17. BCR targets cyclin D2 via Btk and the p85alpha subunit of PI3-K to induce cell cycle progression in primary mouse B cells.
Glassford J; Soeiro I; Skarell SM; Banerji L; Holman M; Klaus GG; Kadowaki T; Koyasu S; Lam EW
Oncogene; 2003 Apr; 22(15):2248-59. PubMed ID: 12700661
[TBL] [Abstract][Full Text] [Related]
18. Bruton's tyrosine kinase mediates NF-kappa B activation and B cell survival by B cell-activating factor receptor of the TNF-R family.
Shinners NP; Carlesso G; Castro I; Hoek KL; Corn RA; Woodland RT; Scott ML; Wang D; Khan WN
J Immunol; 2007 Sep; 179(6):3872-80. PubMed ID: 17785824
[TBL] [Abstract][Full Text] [Related]
19. Bruton's Tyrosine Kinase Synergizes with Notch2 To Govern Marginal Zone B Cells in Nonobese Diabetic Mice.
Case JB; Bonami RH; Nyhoff LE; Steinberg HE; Sullivan AM; Kendall PL
J Immunol; 2015 Jul; 195(1):61-70. PubMed ID: 26034172
[TBL] [Abstract][Full Text] [Related]
20. xid mice reveal the interplay of homeostasis and Bruton's tyrosine kinase-mediated selection at multiple stages of B cell development.
Cancro MP; Sah AP; Levy SL; Allman DM; Schmidt MR; Woodland RT
Int Immunol; 2001 Dec; 13(12):1501-14. PubMed ID: 11717191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
